Form 8-K - Current report:
SEC Accession No. 0001213900-26-052803
Filing Date
2026-05-06
Accepted
2026-05-06 16:07:28
Documents
11
Period of Report
2026-04-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0289520-8k_hoth.htm   iXBRL 8-K 32152
  Complete submission text file 0001213900-26-052803.txt   197608

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hoth-20260422.xsd EX-101.SCH 3038
3 XBRL LABEL FILE hoth-20260422_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE hoth-20260422_pre.xml EX-101.PRE 22374
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0289520-8k_hoth_htm.xml XML 3205
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR SUITE 5066 NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR SUITE 5066 NEW YORK NY 10036 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 26948351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)